Use of CXCR2 antagonists for the prevention and/or treatment of chemotherapy induced peripheral neuropathy (cipn)
- 专利权人:
- GlaxoSmithKline Intellectual Property Development Limited
- 发明人:
- Igboko, Ebere F.,Wren, Paul Bryan
- 申请号：
- AU2015295507
- 公开号：
- AU2015295507A1
- 申请日:
- 2015.07.27
- 申请国别(地区):
- AU
- 年份:
- 2017
- 代理人:
- 摘要：
- The invention relates to the use of a CXCR2 antagonist for the prevention and/or treatment of chemotherapy induced peripheral neuropathy (CIPN).
- 来源网站：
- 中国工程科技知识中心
相关发明人
相关专利
- ПРИМЕНЕНИЕ АНТАГОНИСТОВ CXCR2 ДЛЯ ПРЕДОТВРАЩЕНИЯ И/ИЛИ ЛЕЧЕНИЯ ПЕРИФЕРИЧЕСКОЙ НЕВРОПАТИИ, ВЫЗВАННОЙ ХИМИОТЕРАПИЕЙ (CIPN)
- USE OF CXCR2 ANTAGONISTS FOR THE PREVENTION AND/OR TREATMENT OF CHEMOTHERAPY INDUCED PERIPHERAL NEUROPATHY (CIPN)
- Use of CXCR2 Antagonists For The Prevention and/or Treatment of Chemotherapy Induced Peripheral Neuropathy (CIPN)
- USE OF CXCR2 ANTAGONISTS FOR THE PREVENTION AND/OR TREATMENT OF CHEMOTHERAPY INDUCED PERIPHERAL NEUROPATHY (CIPN)
- UTILISATION D'ANTAGONISTES DE CXCR2 POUR LA PREVENTION ET/OU LE TRAITEMENT DE LA NEUROPATHIE PERIPHERIQUE CHIMIO-INDUITE (NPCI)
